Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

Introduction. Dipeptidyl peptidase-4 (DPP-4) inhibitors improve glycemic control and have pleiotropic effects on kidney injury, albuminuria, and vascular inflammation, especially in animal models. We evaluated the effects of a potent DPP4 inhibitor (gemigliptin) on these processes among patients wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thananda Trakarnvanich, Bancha Satirapoj, Swangjit Suraamornkul, Thanit Chirananthavat, Anoma Sanpatchayapong, Torpong Claimon
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2021/7382620
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
by: Juan Wang, et al.
Published: (2022-11-01)

C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
by: Sevin Demir, et al.
Published: (2016-01-01)

Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis
by: Xiaoyan Liang, et al.
Published: (2025-01-01)

The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
by: Pegah Yousefzadeh, et al.
Published: (2013-01-01)

Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials
by: Jixin Zhong, et al.
Published: (2015-01-01)

Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice
by: Seung Hee Choi, et al.
Published: (2017-01-01)

The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
by: Kazuo Kobayashi, et al.
Published: (2021-01-01)

Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice
by: Wenbin Zheng, et al.
Published: (2018-01-01)

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?
by: Ricardo Godinho, et al.
Published: (2015-01-01)

Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance
by: Wellington S. Silva Júnior, et al.
Published: (2019-01-01)

Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin
by: Katsuya Shibuki, et al.
Published: (2020-01-01)

Effects of dipeptidyl peptidase 4 inhibitors on the risk of acute respiratory failure in patients with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcomes trials
by: Yan Wang, et al.
Published: (2024-12-01)

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease
by: Bancha Satirapoj, et al.
Published: (2015-01-01)

Novel insight into the formation and inhibition mechanism of dipeptidyl peptidase-Ⅳ inhibitory peptides from fermented mandarin fish (Chouguiyu)
by: Daqiao Yang, et al.
Published: (2023-11-01)

Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
by: Bancha Satirapoj, et al.
Published: (2015-01-01)

Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease
by: Simon W. Rabkin
Published: (2011-01-01)

Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
by: Dominique Xavier Brown, et al.
Published: (2012-01-01)

IgG4 Inflammatory Pseudotumor of the Kidney
by: Ahmed N. Alkhasawneh, et al.
Published: (2012-01-01)

Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases
by: Neslihan USLU, et al.
Published: (2024-06-01)

DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Qixian Wang, et al.
Published: (2018-01-01)

DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes
by: Min Qiu, et al.
Published: (2020-01-01)

Erratum to “IgG4 Inflammatory Pseudotumor of the Kidney”
by: Ahmad Alkhasawneh, et al.
Published: (2013-01-01)

Significant Calcification of an Entire Aortic Tree with Renal Artery Subocclusion: Acute Kidney Injury, Ischemic Kidney Disease, and the Tissue Viability Question—A Case Report
by: Marko Baralić, et al.
Published: (2025-01-01)

The Importance of C4d in Biopsies of Kidney Transplant Recipients
by: Rosana Rosa Miranda Corrêa, et al.
Published: (2013-01-01)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
by: Hasniza Zaman Huri, et al.
Published: (2014-01-01)

Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type II
by: Dionysia Amanatidou, et al.
Published: (2025-01-01)

Pathophysiological and Genetic Aspects of Vascular Calcification
by: Luis Fernando Escobar Guzman, et al.
Published: (2020-01-01)

The relationship between radiographic disc calcification score and FGF4L2 genotype in dachshunds
by: Stacey Sullivan, et al.
Published: (2025-01-01)

The deleterious effects of CDK4/6 inhibition on renal recovery post-acute kidney injury
by: Shanshan Zhou, et al.
Published: (2024-11-01)

Comparison of GLP-1 Receptor Agonists, SGLT-2 Inhibitors, and DPP-4 Inhibitors as an Add-On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review
by: Sanbao Chai, et al.
Published: (2024-01-01)

Comparison of citrate dialysate in pre- and post-dilution online hemodiafiltration: effect on clot formation and adequacy of dialysis in hemodialysis patients
by: Pasu Nakornchai, et al.
Published: (2024-12-01)

Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
by: Michiel G. H. Betjes, et al.
Published: (2013-01-01)

Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study
by: Apichaya Chanawong, et al.
Published: (2023-01-01)

Epidemiological Research Advances in Vascular Calcification in Diabetes
by: Haipeng Yao, et al.
Published: (2021-01-01)

IgG4-Related Kidney Disease: Report of a Case Presenting as a Renal Mass
by: Daniele Bianchi, et al.
Published: (2017-01-01)

Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein.
by: June Yao, et al.
Published: (2004-06-01)

Publisher Correction: The deleterious effects of CDK4/6 inhibition on renal recovery post-acute kidney injury
by: Shanshan Zhou, et al.
Published: (2025-01-01)

Radial Artery Calcification in Predicting Coronary Calcification and Atherosclerosis Burden
by: Alexandru Achim, et al.
Published: (2022-01-01)

The Emerging Role of Mesenchymal Stem Cells in Vascular Calcification
by: Changming Xie, et al.
Published: (2019-01-01)

Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study
by: Bancha Satirapoj, et al.
Published: (2016-01-01)